Durvalumab vs Leucovorin Calcium
Durvalumab vs Leucovorin Calcium: Overview
This comparison examines the pharmacological differences between Durvalumab and Leucovorin Calcium.
Mechanism of Action
Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.
Pharmacokinetics
Half-life: Durvalumab β 17 days.
Chemical Properties
Type: Durvalumab β Antibody; Leucovorin Calcium β Small molecule.